Carlsmed (NASDAQ:CARL) Stock Price Expected to Rise, BTIG Research Analyst Says

Carlsmed (NASDAQ:CARL) Stock Price Expected to Rise, BTIG Research Analyst Says

BTIG Research raised their price target on shares of Carlsmed from $24.00 to $26.00 and gave the company a "buy" rating in a report on Wednesday.

Carlsmed (NASDAQ: CARL) raises revenue guidance, sales jump 65% but losses widen

What happened Carlsmed, Inc. (NASDAQ: CARL) raised its full-year 2026 revenue guidance to $78 million to $80 million. Third-quarter revenue grew 65%. The earlier range started at $74 million. Third-quarter revenue was $21.6 million, up from $13.1 million a year earlier. The net loss widened to $12.2 million from $8.5 million, so faster sales came […]